Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the effectiveness of semaglutide in helping children and adolescents with obesity lose weight. The trial is active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 3 | Status: ACTIVE_NOT_RECRUITING